UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047759
Receipt number R000054449
Scientific Title PROFIT
Date of disclosure of the study information 2022/05/16
Last modified on 2023/05/16 09:02:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Questionnaire survey on pregnancy, delivery, and child prognosis in patients with inflammatory bowel disease

Acronym

PROFIT

Scientific Title

PROFIT

Scientific Title:Acronym

PROFIT

Region

Japan


Condition

Condition

Inflammatory Bowel Disease
Ulcerative colitis
Crohn's disease

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim is to build evidence that will be helpful for patients with inflammatory bowel disease to consider pregnancy and childbirth, based on past surveys.

Basic objectives2

Others

Basic objectives -Others

Attitude Survey
natural history survey

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Preference to have a baby
Concerns about pregnancy, childbirth, and childcare
Changes in medical conditions during pregnancy and after delivery
Drugs used during pregnancy
Maternal complications during pregnancy
Maternal complications during pregnancy
Congenital diseases of the child
Development and diseases of the child after birth

Key secondary outcomes

Comparison of miscarriage rates by drug
Breastfeeding Rates
Method of delivery
Infertility treatment
Percentage of discontinuation of medications during pregnancy


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

(1) Patients with a diagnosis of inflammatory bowel disease (ulcerative colitis or Crohn's disease)
(2) Adult female patients
(3) Age of onset less than 50 years old
(4) Any disease type and treatment history

Key exclusion criteria

Cases that the attending physician or principal investigator considers inappropriate

Target sample size

800


Research contact person

Name of lead principal investigator

1st name Yoichi
Middle name
Last name Kakuta

Organization

Tohoku University Hospital

Division name

Division of Gastroenterology

Zip code

980-8574

Address

Sendai

TEL

0227177171

Email

ykakuta@med.tohoku.ac.jp


Public contact

Name of contact person

1st name Sayumi
Middle name
Last name Takahashi

Organization

Tohoku University Hospital

Division name

Division of Gastroenterology

Zip code

980-8574

Address

1-1 Seiryo Aoba, Sendai, Miyagi Japan

TEL

0227177171

Homepage URL


Email

profit@gastroente.med.tohoku.ac.jp


Sponsor or person

Institute

Division of Gastroenterology, Tohoku University Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee, Graduate School of Medicine, Tohoku University

Address

2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan

Tel

022-717-8007

Email

med-kenkyo@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 05 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 05 Month 15 Day

Date of IRB

2022 Year 07 Month 19 Day

Anticipated trial start date

2022 Year 07 Month 20 Day

Last follow-up date

2023 Year 07 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The survey is a non-submitted questionnaire and will not be tracked.


Management information

Registered date

2022 Year 05 Month 15 Day

Last modified on

2023 Year 05 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054449


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name